Olema Pharmaceuticals, Inc. — Form 10-Q
Filed August 10, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
On July 1, 2026, Olema Pharmaceuticals amended its loan agreement with Silicon Valley Bank (now First-Citizens Bank Trust Company) to add an Irish Subsidiary as a secured guarantor. The amendment incorporates Irish law security documents (Irish Security Deed and Irish Shareholder Security Deed) dated July 1, 2026, and establishes the Irish Subsidiary Guaranty. No specific loan amount, interest rate change, or financial terms are disclosed in this amendment document.
Why this rating
Routine amendment adding subsidiary guarantee. No loan amount, terms, or covenants changed materially disclosed. Structural/administrative rather than economically transformative relative to $243M market cap.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.